Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Prakash Gaba, Technical Analyst at prakashgaba.com recommends going long in Infosys and feels that IndusInd Bank may hit Rs 1125 while NTPC may test Rs 155.
Ashwani Gujral of ashwanigujral.com recommends buying DLF, Tata Motors, Dabur India and Aurobindo Pharma and feels that IndusInd Bank may see upside of 5-6 percent.
In an interview with CNBC-TV18, market expert, SP Tulsian gave his stock picks and told why he has a positive stance on all pharma stocks for this coming month.
Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, UPL and Axis Bank.
Prakash Gaba of prakashgaba.com is of the view that Ashok Leyland may test Rs 102 while Sun Pharma may hit Rs 805 and Jain Irrigation may head to Rs 80.
According to Ashwani Gujral of ashwanigujral.com, one can buy Hindustan Petroleum Corporation, Aurobindo Pharma and Bank of India.
On Friday, the day of Brexit referendum results, the benchmark Sensex lost nearly 1,100 points intra-day before closing 604.51 points lower. Investors' wealth in stock market took a hit of nearly Rs 1.8 lakh crore on that day.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Tata Motors, Jet Airways, Orient Bank of Commerce and Aurobindo Pharma.
Brokerage houses do not see any major impact of Brexit on pharma companies' earnings. In fact they have not changed their views post Friday's event, saying companies may get impacted only by currency volatility globally. According to them, any EU impact will offset by US large exposure to the US.
Gaurav Bissa of LKP Securities is of the view that one may buy Bajaj Auto with a target of Rs 2750.
SP Tulsian of sptulsian.com recommends going long in Lupin, Glenmark Pharma, Aurobindo Pharma and Strides Shasun.
Shahina Mukadam, Independent Market Expert is of the view that one may hold Aurobindo Pharma with long term view.
Ashwani Gujral of ashwanigujral.com recommends buying State Bank of India, Motherson Sumi Systems and Aurobindo Pharma.
Ashwani Gujral of ashwanigujral.com recommends buying Escorts, Chambal Fertilisers and Chemicals and Aurobindo Pharma.
Rahul Shah of Motilal Oswal is of the view that one can buy Aurobindo Pharma 720 Put.
Ashwani Gujral of ashwanigujral.com recommends buying SREI Infra and Tata Motors and advises selling Aurobindo Pharma.
Vishal Malkan of malkansview.com is of the view that one can buy Oriental Bank with a target of Rs 94 and SAIL with a target of Rs 49.
Gaurav Bissa of LKP Securities is of the view that one can buy Aurobindo Pharma 740 Put and Granules India 150 Call.
Rajat Bose of rajatkbose.com recommends buying Aurobindo Pharma at around Rs 783.
Sudarshan Sukhani of s2analytics.com recommends buying DLF and Colgate Palmolive and feels that Axis Bank can head higher.
Ashwani Gujral of ashwanigujral.com recommends buying Aurobindo Pharma, DLF and Biocon.
Ashwani Gujral of ashwanigujral.com recommends buying JSW Steel, UPL, Aurobindo Pharma and advises selling Jain Irrigation Systems.
Ashwani Gujral, Fund manager at ashwanigujral.com is of the view that one can buy Aurobindo Pharma, Reliance Infrastructure and Reliance Capital.
Ashwani Gujral of ashwanigujral.com recommends buying Ambuja Cements and advises selling Idea Cellular and Aurobindo Pharma.
R Sreesankar, Head Institutional Equities, Prabhudas Lilladher in an interview to CNBC-TV18 shared his rationale for picking Infosys, HDFC Bank, Aurobindo Pharma, Jubilant Life and Glenmark as his top picks.